Gilde Healthcare - a transatlantic investor in fast growing healthcare technology and healthcare services companies - has joined NIZO food research as a shareholder to facilitate long term growth.
Gilde Healthcare has joined NIZO food research as a shareholder to facilitate long term growth.The current strategy to grow internationally in contract research is supplemented with new, innovative business models,” said Ad Juriaanse, CEO. “For example, NIZO has recently developed in-house product innovations such as fibres based on plant proteins and fat-free ice cream. It also is one of the few companies worldwide that operates a state-of-the-art pilot plant to actually produce these innovations. We see this transaction as recognition of our company’s strong market position and the expertise of our staff”. “Research in health and food are converging, with the pharmaceutical industry looking at effects of food components and the food sector becoming more aware of the health effects of their products,” said Jasper van Gorp, Managing Partner at Gilde Healthcare. “Examples of this convergence include functional foods, probiotics, nutraceuticals and clinical nutrition. At the same time very few companies globally have the right expertise to make the connection between food and health. NIZO is a growth center for innovative R&D services and new product and process innovations in this field”.Gilde Healthcare is a transatlantic investor in fast growing healthcare technology and healthcare services companies. To date, Gilde Healthcare has over €550 million under management. Gilde Healthcare’s funds include technological innovations as well as healthcare services companies such as midsized healthcare providers and service providers. In collaboration with NIZO’s management team, Gilde Healthcare aims to focus on accelerating NIZO’s autonomous growth and adding complementary activities.